Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Christopher T. Campbell"'
Autor:
Christopher T. Campbell, Sean R. Llewellyn, Thorsten Demberg, Ian L. Morgan, Marjorie Robert-Guroff, Jeffrey C. Gildersleeve
Publikováno v:
PLoS ONE, Vol 8, Iss 12 (2013)
Externí odkaz:
https://doaj.org/article/2339b7df94f645ffa95e7d9e622468ae
Autor:
Jeffrey C. Gildersleeve, Jeffrey Schlom, James W. Hodge, Oyindasola Oyelaran, James L. Gulley, Christopher T. Campbell
PDF file - 112K, Summary of survival correlations for pre-vaccination antibody levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9d959224cf8eb8f02bedfd086952a9
https://doi.org/10.1158/1078-0432.22449932.v1
https://doi.org/10.1158/1078-0432.22449932.v1
Autor:
Jeffrey C. Gildersleeve, Jeffrey Schlom, James W. Hodge, Oyindasola Oyelaran, James L. Gulley, Christopher T. Campbell
PDF file - 58K, Secondary antibodies for fluorescent labeling of serum anti-glycan antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beab497fc71ea4167e9d99b18b6b2dba
https://doi.org/10.1158/1078-0432.22449929.v1
https://doi.org/10.1158/1078-0432.22449929.v1
Autor:
Jeffrey C. Gildersleeve, Jeffrey Schlom, James W. Hodge, Oyindasola Oyelaran, James L. Gulley, Christopher T. Campbell
Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some patients with cancer, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insight
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd4d33296f58e693f35786afc064e0c
https://doi.org/10.1158/1078-0432.c.6521801
https://doi.org/10.1158/1078-0432.c.6521801
Autor:
Jeffrey C. Gildersleeve, Jeffrey Schlom, James W. Hodge, Oyindasola Oyelaran, James L. Gulley, Christopher T. Campbell
PDF file - 156K, Description of Array Components
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87bbf43582c431162df5b8706970fcd7
https://doi.org/10.1158/1078-0432.22449935.v1
https://doi.org/10.1158/1078-0432.22449935.v1
Autor:
Joseph Philip, Desiree S Machado, Brian Kelly, Christopher T. Campbell, Saleem Islam, Mark S. Bleiweis, Donald Harrington, J. Peter R. Pelletier, Cynthia Garvan, Giles J. Peek, Bruce D. Spiess
Publikováno v:
ASAIO Journal. 67:688-696
We retrospectively compared anticoagulation with heparin and bivalirudin for 32 consecutive children under 18 years old during extracorporeal membrane oxygenation (ECMO) in our pediatric cardiac intensive care unit (PCICU). Between September 2015 and
Publikováno v:
Annals of Pharmacotherapy. 54:464-469
Background: Risperidone dosing and safety data are limited in patients ≤2 years of age. Objective: To describe the dosing strategies, safety, and tolerability of risperidone in infants ≤2 years of age. Methods: An institutional review board–app
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 45:335-339
What is known and objective As the global adoption of ENFit-compatible syringes becomes more widespread, it is important for syringe users to understand the risk of dosing inaccuracy for both the oral and enteral routes of use. Describing the risk of
Autor:
Bailey Brewer, Tasha Stoiber, Jared Hayes, Christopher T. Campbell, David Q. Andrews, Olga V. Naidenko
Publikováno v:
AWWA Water Science. 3
Publikováno v:
ISEE Conference Abstracts. 2021